Comprehensive analysis of hub biomarkers associated with immune and oxidative stress in Hashimoto's thyroiditis.
暂无分享,去创建一个
Bojin Xu | Juanjuan Du | Guanjun Cai | Shan Huang | Wenfang Peng | Xiaoxu Ge | Xiao-Hua Wu | Haiping Zhou | Yiming Guo
[1] Q. Qin,et al. High iodine promotes autoimmune thyroid disease by activating hexokinase 3 and inducing polarization of macrophages towards M1 , 2022, Frontiers in Immunology.
[2] A. Petit,et al. LYMPHOCYTIC THYROIDITIS TRANSCRIPTOMIC PROFILES SUPPORT THE ROLE OF CHECKPOINT PATHWAYS AND B CELLS IN PATHOGENESIS. , 2022, Thyroid : official journal of the American Thyroid Association.
[3] Wei Liu,et al. Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto’s thyroiditis , 2022, Nature communications.
[4] Lulu Chen,et al. Integrative Analyses of Genes Associated with Hashimoto's Thyroiditis , 2021, Journal of immunology research.
[5] Yu Pan,et al. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer , 2021, International journal of medical sciences.
[6] R. Touyz,et al. Oxidative Stress and Hypertension , 2021, Circulation research.
[7] R. Schulz,et al. Multifunctional intracellular matrix metalloproteinases: implications in disease , 2021, The FEBS journal.
[8] Elena Butturini,et al. Redox Regulation of STAT1 and STAT3 Signaling , 2020, International journal of molecular sciences.
[9] J. Casanova,et al. Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy , 2020, Journal of Clinical Immunology.
[10] M. Fiore,et al. Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. , 2020, Autoimmunity reviews.
[11] W. Qu,et al. Bioinformatics analysis of key genes and pathways in Hashimoto thyroiditis tissues , 2020, Bioscience reports.
[12] Sajjad Karim,et al. Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis , 2020, PloS one.
[13] Kyung Min Lim,et al. Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion , 2020, Journal of clinical medicine.
[14] O. Ohara,et al. Autosomal dominant Hashimoto’s thyroiditis with a mutation in TNFAIP3 , 2019, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.
[15] J. Witkowski,et al. Immunological aspects of autoimmune thyroid disease – Complex interplay between cells and cytokines , 2019, Cytokine.
[16] S. Kurtoğlu,et al. Neonatal effects of thyroid diseases in pregnancy and approach to the infant with increased TSH: Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report , 2018, Turk pediatri arsivi.
[17] D. Berker,et al. The effect of oxidative stress on the progression of Hashimoto’s thyroiditis , 2018, Archives of physiology and biochemistry.
[18] F. Esfahanian,et al. Increased Levels of Serum Interleukin-17 in Patients with Hashimoto's Thyroiditis , 2017, Indian journal of endocrinology and metabolism.
[19] W. Teng,et al. Glycyrrhizin, a Direct HMGB1 Antagonist, Ameliorates Inflammatory Infiltration in a Model of Autoimmune Thyroiditis via Inhibition of TLR2-HMGB1 Signaling. , 2017, Thyroid : official journal of the American Thyroid Association.
[20] M. Rayman,et al. Multiple Nutritional Factors and the Risk of Hashimoto's Thyroiditis. , 2017, Thyroid : official journal of the American Thyroid Association.
[21] M. Alevizaki,et al. RAGE polymorphisms and oxidative stress levels in Hashimoto's thyroiditis , 2017, European journal of clinical investigation.
[22] The Gene Ontology Consortium,et al. Expansion of the Gene Ontology knowledgebase and resources , 2016, Nucleic Acids Res..
[23] A. Kalkancı,et al. Circulating Th17 cytokine levels are altered in Hashimoto's thyroiditis. , 2016, Cytokine.
[24] D. Berker,et al. The relationship between oxidative stress and autoimmunity in Hashimoto's thyroiditis. , 2015, European journal of endocrinology.
[25] Jeffrey L Carson,et al. Proteolytic Cleavage of AMPKα and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1α Expression in Leukocytes , 2015, The Journal of Immunology.
[26] J. Roliński,et al. Immune Disorders in Hashimoto's Thyroiditis: What Do We Know So Far? , 2015, Journal of immunology research.
[27] S. Moretti,et al. Oxidative Stress and Immune System in Vitiligo and Thyroid Diseases , 2015, Oxidative medicine and cellular longevity.
[28] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[29] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[30] Jin-an Zhang,et al. Polymorphisms of the TNFAIP3 region and Graves' disease , 2014, Autoimmunity.
[31] A. Patel,et al. Oxidative stress and antioxidants in disease and cancer: a review. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[32] Inmoo Rhee,et al. Control of Dendritic Cell Migration, T Cell-Dependent Immunity, and Autoimmunity by Protein Tyrosine Phosphatase PTPN12 Expressed in Dendritic Cells , 2013, Molecular and Cellular Biology.
[33] F. Sung,et al. Cancer risk in patients with Hashimoto's thyroiditis: a nationwide cohort study , 2013, British Journal of Cancer.
[34] D. Cooper,et al. The incidence and prevalence of thyroid autoimmunity , 2012, Endocrine.
[35] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[36] Rosalind S. Brown,et al. Autoimmune Thyroid Disorders , 2011, Journal of thyroid research.
[37] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[38] E. Zeggini,et al. Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritis , 2010, Human Genetics.
[39] J. Cracowski,et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population , 2010, Annals of the rheumatic diseases.
[40] Constantin Polychronakos,et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. , 2010, Human molecular genetics.
[41] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[42] Michael D Schaller,et al. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions , 2010, Journal of Cell Science.
[43] K. Eguchi,et al. T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. , 2009, Endocrinology.
[44] G. Herrero-Beaumont,et al. Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility , 2009, Arthritis research & therapy.
[45] S. Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[46] Y. Shoenfeld,et al. Hepatitis B Virus (HBV) and Autoimmune Disease , 2008, Clinical reviews in allergy & immunology.
[47] A. Morris,et al. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS) , 2007, Clinical endocrinology.
[48] William C. Parks,et al. Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.
[49] W Harry Hannon,et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.
[50] Y. Miyamoto,et al. Activation of Matrix Metalloproteinases by Peroxynitrite-induced Protein S-Glutathiolation via Disulfide S-Oxide Formation* , 2001, The Journal of Biological Chemistry.
[51] R. Beyaert,et al. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.
[52] A. Ma,et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.
[53] Jianguo Xia,et al. miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context. , 2018, Methods in molecular biology.
[54] Yen-Kung Chen,et al. Hashimoto's thyroiditis, risk of coronary heart disease, and L-thyroxine treatment: a nationwide cohort study. , 2015, The Journal of clinical endocrinology and metabolism.
[55] D. Vergani,et al. Autoimmune manifestations in viral hepatitis , 2012, Seminars in Immunopathology.
[56] Rudi Beyaert,et al. A20 inhibits NF-κB activation by dual ubiquitin-editing functions , 2005 .
[57] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..